PERIHILAR CHOLANGIOCARCINOMA
Clinical trials for PERIHILAR CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PERIHILAR CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for PERIHILAR CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heat therapy before stenting may extend bile duct patency in cancer patients
Disease control Recruiting nowThis study tests whether using heat (radiofrequency ablation) to destroy cancer tissue inside the bile duct before placing a metal stent can keep the duct open longer than placing a stent alone. It involves 122 adults with inoperable bile duct cancer. The main goal is to see how …
Matched conditions: PERIHILAR CHOLANGIOCARCINOMA
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Personalized cancer care: new trial aims to improve outcomes in biliary cancer
Disease control Recruiting nowThis phase 3 trial is testing whether giving a targeted therapy after initial standard chemotherapy can help people with advanced biliary cancer live longer without their disease getting worse. Participants must have a tumor with a specific genetic change and stable disease after…
Matched conditions: PERIHILAR CHOLANGIOCARCINOMA
Phase: PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for bile duct cancer: experimental drug takes on chemo
Disease control Recruiting nowThis study tests a new drug called ivonescimab against standard chemotherapy (FOLFOX) for people with advanced bile duct cancer that has worsened after initial treatment. About 72 participants who were in the SAFIR-ABC10 trial will be randomly assigned to receive either ivonescim…
Matched conditions: PERIHILAR CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Promising combo therapy shows hope for Hard-to-Treat bile duct cancer
Disease control Recruiting nowThis study is testing a treatment strategy for biliary tract cancer, a group of aggressive cancers with poor survival. The approach combines hepatic arterial infusion chemotherapy (HAIC) with systemic drugs like bevacizumab and an immunotherapy. The goal is to shrink tumors and i…
Matched conditions: PERIHILAR CHOLANGIOCARCINOMA
Phase: NA • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Liver transplant offers new hope for incurable bile duct cancer
Disease control Recruiting nowThis study looks at whether a liver transplant can help people with a type of bile duct cancer (perihilar cholangiocarcinoma) that cannot be surgically removed. About 50 participants will receive standard chemotherapy followed by a liver transplant. Researchers will track how lon…
Matched conditions: PERIHILAR CHOLANGIOCARCINOMA
Phase: NA • Sponsor: Azienda Sanitaria Ospedaliera • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New hope for bile duct cancer: immunotherapy plus chemo after surgery
Disease control Recruiting nowThis phase II trial is testing whether adding an immunotherapy drug (PD-1 antibody) to standard chemotherapy (GEMOX) after surgery can help prevent cancer from returning in people with perihilar cholangiocarcinoma that has spread to nearby lymph nodes. The study plans to enroll 6…
Matched conditions: PERIHILAR CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC